Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares ER and PR negative under 1 percent (the triple-negative threshold, and ER-low), HER2 testing in the UK: reflex ISH, the ratio against the copy number, and where the UK differs from ASCO/CAP, DESTINY-Breast04, HER2-low and HER2-ultralow metastatic breast cancer and the tag breast.
Shares Chemoprevention (tamoxifen, anastrozole, raloxifene) and ER-negative breast cancer, Mastectomy, Germline (hereditary) testing, Breast cancer (all types) and the tag breast.
Shares The WHO classification of breast tumours, and what the 6th edition changed, BRCA1 / BRCA2 (HRD), Breast cancer (all types), Triple-negative breast cancer (TNBC) and the tag breast.
Shares BRCA1 / BRCA2 (HRD), Germline (hereditary) testing, Breast cancer (all types), Triple-negative breast cancer (TNBC) and the tag breast.
Shares BRCA1 / BRCA2 (HRD), Germline (hereditary) testing, Breast cancer (all types), Triple-negative breast cancer (TNBC) and the tag breast.
Shares PARP, PARP inhibitors, Olaparib, BRCA1 / BRCA2 (HRD) and the tag breast.
Shares OlympiA, Olaparib, Breast cancer (all types), Triple-negative breast cancer (TNBC) and the tag breast.
Shares Breast cancer (all types), Triple-negative breast cancer (TNBC) and the tag breast.
The same record for scripts and assistants; checked 2026-09-25. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.